The global market for Bifidobacteria Probiotic is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Bifidobacteria Probiotic players cover Chr. Hansen Holding A/S, BioGaia AB, Probi AB, DowDuPont Inc. and Nestl? S.A., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Bifidobacteria Probiotic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Bifidobacteria Probiotic market, with both quantitative and qualitative data, to help readers understand how the Bifidobacteria Probiotic market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Bifidobacteria Probiotic market and forecasts the market size by Type (Dry and Liquid,), by Application (Hypermarket/Supermarket, Medical Stores, Specialty Stores and Online Stores), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Dry
Liquid
Segmentation by application
Hypermarket/Supermarket
Medical Stores
Specialty Stores
Online Stores
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Chr. Hansen Holding A/S
BioGaia AB
Probi AB
DowDuPont Inc.
Nestl? S.A.
Procter & Gamble Company
Probiotics International Limite
Lallemand Inc
PharmaCare Laboratories
Dr. Willmar Schwabe Group
SymbioPharm GmbH
Pfizer
Incal Health
Chapter Introduction
Chapter 1: Scope of Bifidobacteria Probiotic, Research Methodology, etc.
Chapter 2: Executive Summary, global Bifidobacteria Probiotic market size (sales and revenue) and CAGR, Bifidobacteria Probiotic market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Bifidobacteria Probiotic sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Bifidobacteria Probiotic sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Bifidobacteria Probiotic market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Chr. Hansen Holding A/S, BioGaia AB, Probi AB, DowDuPont Inc., Nestl? S.A., Procter & Gamble Company, Probiotics International Limite, Lallemand Inc and PharmaCare Laboratories, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bifidobacteria Probiotic Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bifidobacteria Probiotic by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bifidobacteria Probiotic by Country/Region, 2017, 2022 & 2028
2.2 Bifidobacteria Probiotic Segment by Type
2.2.1 Dry
2.2.2 Liquid
2.3 Bifidobacteria Probiotic Sales by Type
2.3.1 Global Bifidobacteria Probiotic Sales Market Share by Type (2017-2022)
2.3.2 Global Bifidobacteria Probiotic Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bifidobacteria Probiotic Sale Price by Type (2017-2022)
2.4 Bifidobacteria Probiotic Segment by Application
2.4.1 Hypermarket/Supermarket
2.4.2 Medical Stores
2.4.3 Specialty Stores
2.4.4 Online Stores
2.5 Bifidobacteria Probiotic Sales by Application
2.5.1 Global Bifidobacteria Probiotic Sale Market Share by Application (2017-2022)
2.5.2 Global Bifidobacteria Probiotic Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bifidobacteria Probiotic Sale Price by Application (2017-2022)
3 Global Bifidobacteria Probiotic by Company
3.1 Global Bifidobacteria Probiotic Breakdown Data by Company
3.1.1 Global Bifidobacteria Probiotic Annual Sales by Company (2020-2022)
3.1.2 Global Bifidobacteria Probiotic Sales Market Share by Company (2020-2022)
3.2 Global Bifidobacteria Probiotic Annual Revenue by Company (2020-2022)
3.2.1 Global Bifidobacteria Probiotic Revenue by Company (2020-2022)
3.2.2 Global Bifidobacteria Probiotic Revenue Market Share by Company (2020-2022)
3.3 Global Bifidobacteria Probiotic Sale Price by Company
3.4 Key Manufacturers Bifidobacteria Probiotic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bifidobacteria Probiotic Product Location Distribution
3.4.2 Players Bifidobacteria Probiotic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bifidobacteria Probiotic by Geographic Region
4.1 World Historic Bifidobacteria Probiotic Market Size by Geographic Region (2017-2022)
4.1.1 Global Bifidobacteria Probiotic Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bifidobacteria Probiotic Annual Revenue by Geographic Region
4.2 World Historic Bifidobacteria Probiotic Market Size by Country/Region (2017-2022)
4.2.1 Global Bifidobacteria Probiotic Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bifidobacteria Probiotic Annual Revenue by Country/Region
4.3 Americas Bifidobacteria Probiotic Sales Growth
4.4 APAC Bifidobacteria Probiotic Sales Growth
4.5 Europe Bifidobacteria Probiotic Sales Growth
4.6 Middle East & Africa Bifidobacteria Probiotic Sales Growth
5 Americas
5.1 Americas Bifidobacteria Probiotic Sales by Country
5.1.1 Americas Bifidobacteria Probiotic Sales by Country (2017-2022)
5.1.2 Americas Bifidobacteria Probiotic Revenue by Country (2017-2022)
5.2 Americas Bifidobacteria Probiotic Sales by Type
5.3 Americas Bifidobacteria Probiotic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bifidobacteria Probiotic Sales by Region
6.1.1 APAC Bifidobacteria Probiotic Sales by Region (2017-2022)
6.1.2 APAC Bifidobacteria Probiotic Revenue by Region (2017-2022)
6.2 APAC Bifidobacteria Probiotic Sales by Type
6.3 APAC Bifidobacteria Probiotic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bifidobacteria Probiotic by Country
7.1.1 Europe Bifidobacteria Probiotic Sales by Country (2017-2022)
7.1.2 Europe Bifidobacteria Probiotic Revenue by Country (2017-2022)
7.2 Europe Bifidobacteria Probiotic Sales by Type
7.3 Europe Bifidobacteria Probiotic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bifidobacteria Probiotic by Country
8.1.1 Middle East & Africa Bifidobacteria Probiotic Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bifidobacteria Probiotic Revenue by Country (2017-2022)
8.2 Middle East & Africa Bifidobacteria Probiotic Sales by Type
8.3 Middle East & Africa Bifidobacteria Probiotic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bifidobacteria Probiotic
10.3 Manufacturing Process Analysis of Bifidobacteria Probiotic
10.4 Industry Chain Structure of Bifidobacteria Probiotic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bifidobacteria Probiotic Distributors
11.3 Bifidobacteria Probiotic Customer
12 World Forecast Review for Bifidobacteria Probiotic by Geographic Region
12.1 Global Bifidobacteria Probiotic Market Size Forecast by Region
12.1.1 Global Bifidobacteria Probiotic Forecast by Region (2023-2028)
12.1.2 Global Bifidobacteria Probiotic Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bifidobacteria Probiotic Forecast by Type
12.7 Global Bifidobacteria Probiotic Forecast by Application
13 Key Players Analysis
13.1 Chr. Hansen Holding A/S
13.1.1 Chr. Hansen Holding A/S Company Information
13.1.2 Chr. Hansen Holding A/S Bifidobacteria Probiotic Product Offered
13.1.3 Chr. Hansen Holding A/S Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Chr. Hansen Holding A/S Main Business Overview
13.1.5 Chr. Hansen Holding A/S Latest Developments
13.2 BioGaia AB
13.2.1 BioGaia AB Company Information
13.2.2 BioGaia AB Bifidobacteria Probiotic Product Offered
13.2.3 BioGaia AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BioGaia AB Main Business Overview
13.2.5 BioGaia AB Latest Developments
13.3 Probi AB
13.3.1 Probi AB Company Information
13.3.2 Probi AB Bifidobacteria Probiotic Product Offered
13.3.3 Probi AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Probi AB Main Business Overview
13.3.5 Probi AB Latest Developments
13.4 DowDuPont Inc.
13.4.1 DowDuPont Inc. Company Information
13.4.2 DowDuPont Inc. Bifidobacteria Probiotic Product Offered
13.4.3 DowDuPont Inc. Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 DowDuPont Inc. Main Business Overview
13.4.5 DowDuPont Inc. Latest Developments
13.5 Nestl